Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 3.41
    Last
  • 0.35  -9.31%
    Today's Change
  • 3.76
    Previous Close
  • Today
     
    1.24
    15.68
    52 Week Low - High
5:20 pm ET 10/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding8 million
Market Cap$28 million
Return on Equity ttm-191.72%
Last DividendCLSN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-8.017
EPS: Year Est. 12/17 ttm-3.030
 
EPS: Quarterly Actual 6/17 -0.76
EPS: Quarterly Est. 9/17 -0.56
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate17.48
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Revenue$500,000
Net Income$-22 million
Total Assets$31 million
Employees19
Web Sitewww.celsion.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!